Multiple System Atrophy
📧 Sign up to get email alerts when something new happens for Multiple System Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: A Biomarker Study of ATH434 in Participants With MSA [Phase 2]
A Phase 2 biomarker study evaluating ATH434 in participants with Multiple System Atrophy has completed. The update notes the trial status an…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy
A clinical trial is evaluating TSPO PET imaging to assess neuroinflammation in patients with multiple system atrophy (MSA), including the ce…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy
A clinical trial investigating targeted alpha-synuclein PET imaging to aid diagnosis of multiple system atrophy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely [NA]
A NeuraLight-sponsored clinical trial is enrolling by invitation to evaluate routine oculometric pattern measurements for distinguishing Par…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Trial of Parkinson's And Zoledronic Acid [Phase 4]
A Phase 4 trial investigating zoledronic acid in patients with Parkinson's disease and osteoporosis is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein [Phase 1]
Phase 1 proof-of-mechanism study to evaluate binding of Alfa-synuclein has completed, involving Parkinson's disease and multiple system atro…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Transcutaneous Spinal Cord Stimulation Home Study [NA]
A home-based study of transcutaneous spinal cord stimulation is currently recruiting participants for spinal cord injuries, multiple system …
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Application of 18F-CP6A PET Imaging in Synucleinopathies [EARLY_Phase 1]
An early-phase 1 trial is investigating the PET imaging tracer 18F-CP6A for synucleinopathies, with the study not yet recruiting. The sponso…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating imaging tracers [18F]-MFBG, [123I]-MIBG, and [18F]-PE2I to differentiate Parkinson disease from multiple…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Medical Decision Making in Multiple System Atrophy [NA]
A clinical trial in Innsbruck is currently recruiting to study medical decision making in patients with Multiple System Atrophy.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) [Phase 1]
Phase 1 study evaluating the investigational allogeneic cell therapy product hOMSC300 for early to moderate stage Multiple System Atrophy (M…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism [Phase 2]
A Phase 2 randomized, double-blind trial evaluating NAD replenishment therapy for atypical parkinsonism is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System
Enrollment by invitation is ongoing for a prodromal Parkinson's disease model confined to the peripheral nervous system.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
This note reports long-term follow-up results from a Phase 1 trial of CS10BR05 (MSA101) in patients with Multiple System Atrophy, completed …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Lu AF82422 in Participants With Multiple System Atrophy [Phase 2]
Phase 2 trial update for Lu AF82422 in participants with multiple system atrophy, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Study of ATH434 in Participants with Multiple System Atrophy [Phase 2]
Phase 2 study of ATH434 in participants with Multiple System Atrophy has completed.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders [NA]
This entry provides an update on a clinical trial evaluating CUE1 and CUE1+ in people with Parkinson's disease and related disorders; recrui…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: North American Prodromal Synucleinopathy Consortium
This update covers the North American Prodromal Synucleinopathy Consortium trial led by Washington University School of Medicine. Enrollment…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: North American Prodromal Synucleinopathy Consortium Stage 2
This clinical trial update announces Stage 2 of the North American Prodromal Synucleinopathy Consortium, which is currently recruiting to st…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy [Phase 1]
Phase 1 trial assessing safety and tolerability of CS10BR05 Injection in individuals with Multiple System Atrophy has completed.
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
This ongoing study aims to understand how atypical parkinsonian syndromes affect health-care utilization and quality of life in patients.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
A clinical trial update evaluating progression markers in neurodegenerative diseases, including Parkinson's disease, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) [Phase 2]
Phase 2 trial evaluating KM-819 to slow progression of Multiple System Atrophy has been terminated.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy
The TRACK-MSA longitudinal study, sponsored by NYU Langone Health, has completed and aims to define outcome measures for Multiple System Atr…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Biomarkers in Parkinsonian Syndromes
An ongoing clinical trial is recruiting to investigate biomarkers across Parkinsonian syndromes, including Parkinson's disease and Progressi…